NewAmsterdam Pharma
NAMS
NAMS
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
101
Artal Group
Luxembourg
| – | -$15.4M | -800,000 | Closed |
|
|
SCM
102
Superstring Capital Management
New York
| – | -$1.23M | -64,213 | Closed |
|
|
SSA
103
Schonfeld Strategic Advisors
New York
| – | -$950K | -49,433 | Closed |
|
|
JGC
104
J. Goldman & Co
New York
| – | -$706K | -36,776 | Closed |
|
|
VPC
105
Vestal Point Capital
New York
| – | -$480K | -25,000 | Closed |
|
|
ACP
106
Acuta Capital Partners
Redwood City,
California
| – | -$432K | -22,500 | Closed |
|
|
YIH
107
Y-Intercept (HK)
Hong Kong
| – | -$281K | -14,607 | Closed |
|
|
PL
108
Parkwood LLC
Cleveland,
Ohio
| – | -$265K | -13,782 | Closed |
|
109
State of Wisconsin Investment Board
Madison,
Wisconsin
| – | -$234K | -12,171 | Closed |
|
|
BCV
110
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| – | -$38K | -2,000 | Closed |
|